Campbell & Co Investment Adviser’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Buy |
+40,191
| New | +$715K | 0.05% | 649 |
|
|
2024
Q3 | – | Sell |
-15,776
| Closed | -$270K | – | 1252 |
|
|
2024
Q2 | $270K | Buy |
+15,776
| New | +$270K | 0.02% | 865 |
|
|
2023
Q4 | – | Sell |
-46,416
| Closed | -$750K | – | 1272 |
|
|
2023
Q3 | $750K | Buy |
+46,416
| New | +$750K | 0.09% | 369 |
|
|
2022
Q3 | – | Sell |
-3,066
| Closed | -$213K | – | 857 |
|
|
2022
Q2 | $213K | Buy |
+3,066
| New | +$213K | 0.06% | 585 |
|
|
2022
Q1 | – | Sell |
-7,200
| Closed | -$541K | – | 835 |
|
|
2021
Q4 | $541K | Buy |
+7,200
| New | +$541K | 0.19% | 175 |
|
|
2021
Q3 | – | Sell |
-1,300
| Closed | -$288K | – | 705 |
|
|
2021
Q2 | $288K | Buy |
+1,300
| New | +$288K | 0.12% | 336 |
|
|
2020
Q1 | – | Sell |
-2,848
| Closed | -$240K | – | 356 |
|
|
2019
Q4 | $240K | Buy |
+2,848
| New | +$240K | 0.07% | 509 |
|
|
2019
Q3 | – | Sell |
-3,805
| Closed | -$241K | – | 710 |
|
|
2019
Q2 | $241K | Buy |
+3,805
| New | +$241K | 0.11% | 398 |
|
|
2018
Q3 | – | Sell |
-7,700
| Closed | -$241K | – | 482 |
|
|
2018
Q2 | $241K | Buy |
+7,700
| New | +$241K | 0.19% | 261 |
|